Zhu, C., Wu, F., Xu, Z., Li, C., Di, L., Zhao, X., Tan, Y., Wang, S., Liu, K., Zhao, H., Zeng, D., Li, G. (2025). TACE with or without lenvatinib as adjuvant therapy for HCC with microvascular invasion (MVI) or portal vein thrombus (Cheng’s I/II): A single-center, prospective, non-randomized cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16214